Podcast Episodes
Back to Search
Opioids, cancer and mortality with Aleksi Hamina
Season 2 Episode 37
In this episode Ben Scher talks to Dr Aleksi Hamina from the Norwegian centre for addiction research at the University of Oslo and the Niuvanniemi Hospital in Finland. They discuss a recent paper co-…
Published on 1 year, 3 months ago
Cannabis potency and psychotic experiences with Lindsey Hines
Season 2 Episode 36
In this episode, Dr Rob Calder talks to Dr Lindsey Hines about her study using longitudinal data to examine links between cannabis use, cannabis potency and psychotic experiences. Dr Hines talks abou…
Published on 1 year, 5 months ago
Cannabis use in the US with Jonathan Caulkins
Season 2 Episode 35
In this episode Dr Elle Wadsworth talks to Professor Jonathan Caulkins about self-reported cannabis use in the US between 1979 and 2022 and how those trends compare with alcohol use over the same per…
Published on 1 year, 5 months ago
Integrated care vans with Kathleen Page
Season 2 Episode 34
In this episode, Ben Scher talks to Dr Kathleen Page about her evaluation of an integrated care van that ran in Baltimore offering healthcare interventions and buprenorphine prescribing. Dr Page disc…
Published on 1 year, 6 months ago
Smoking and abdominal obesity with Germán Carrasquilla
Season 2 Episode 33
In this episode Rob Calder talks to Dr Germán Carrasquilla about his study assessing whether smoking cased increases in abdominal obesity or belly fat. They discuss the implications of this kind of f…
Published on 1 year, 6 months ago
Benzodiazepines and treatment with Adam Bakker, Michael Liebrenz and Alexander Smith
Season 2 Episode 31
In this episode Ben Scher talks to Dr Adam Bakker, Professor Michael Liebrenz and Dr Alexander Smith about their commentary in response to a previous paper by Domzaridou and colleages (2023). They di…
Published on 1 year, 6 months ago
Contingency management with Gabriela Khazanov, James, McKay and Richard Rawson
Season 2 Episode 32
In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment sett…
Published on 1 year, 6 months ago
Xylazine, heroin and drug markets with Caroline Copeland
Season 2 Episode 30
In this episode Ben Scher talks to Dr Caroline Copeland about her work analysing drug death data to identify drug use trends, harms and to inform policy. Caroline talks about how xylazine first enter…
Published on 1 year, 7 months ago
Synthetic opioid production in Europe with Paul Griffiths
Season 2 Episode 29
In this episode, Dr Elle Wadsworth talks to Paul Griffiths about synthetic drug production in Europe including the differences between lab-made substances and diverted medical drugs. They discuss org…
Published on 1 year, 7 months ago
Alcohol-free drinks in the US with Molly Bowdring
Season 2 Episode 28
In this episode Dr Merve Mollaahmetoglu talks to Dr Molly Bowdring about her recent article on the impact of alcohol-free drinks such as zero-percent beers, wines and mocktails. Molly talks about usi…
Published on 1 year, 8 months ago